As of 2025-07-02, the Relative Valuation of Homology Medicines Inc (FIXX) is (1,089.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.55 USD, the upside of Homology Medicines Inc based on Relative Valuation is -4539.6%.
The range of the Relative Valuation is (839.70) - (1,499.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 17.7x | 12.6x |
| Forward P/E multiples | 9.9x - 20.1x | 13.1x |
| Fair Price | (839.70) - (1,499.59) | (1,089.91) |
| Upside | -3520.4% - -6208.3% | -4539.6% |
| Date | P/E |